Generalizability and effect measure modification in sibling comparison studies.

Bias Causal inference Effect measure modification Sibling comparison study

Journal

European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062

Informations de publication

Date de publication:
May 2022
Historique:
received: 27 08 2021
accepted: 16 01 2022
pubmed: 22 3 2022
medline: 23 6 2022
entrez: 21 3 2022
Statut: ppublish

Résumé

Sibling comparison studies have the attractive feature of being able to control for unmeasured confounding by factors that are shared within families. However, there is sometimes a concern that these studies may have poor generalizability (external validity) due to the implicit restriction to families that are covariate-discordant, i.e., those families where at least two siblings have different levels of at least one of the covariates (exposure or confounders) under investigation. Even if this selection mechanism has been noted by many authors, previous accounts of the problem tend to be brief. The purpose of this paper is to provide a formal discussion of the implicit restriction to covariate-discordant families in sibling comparison studies. We discuss when and how this restriction may impair the generalizability of the study, and we show that a similar generalizability problem may in fact arise even when all families are covariate-discordant, e.g. even if the exposure is continuous so that all siblings have different exposure levels. We show how this problem can be solved by using a so-called marginal between-within model for estimation of marginal exposure effects. Finally, we illustrate the theoretical conclusions with a simulation study.

Identifiants

pubmed: 35312926
doi: 10.1007/s10654-022-00844-x
pii: 10.1007/s10654-022-00844-x
pmc: PMC9209381
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

461-476

Subventions

Organisme : Vetenskapsrådet
ID : 2020-01188
Organisme : Vetenskapsrådet
ID : 2016-01355

Informations de copyright

© 2022. The Author(s).

Références

Epidemiology. 2019 Mar;30(2):234-242
pubmed: 30516650
Paediatr Perinat Epidemiol. 2021 Jul;35(4):404-414
pubmed: 32189375
Am J Epidemiol. 2019 Jan 1;188(1):17-21
pubmed: 30188975
BMJ. 2019 Dec 4;367:l6398
pubmed: 31801789
Epidemiology. 2012 Sep;23(5):713-20
pubmed: 22781362
Int J Epidemiol. 2011 Apr;40(2):345-9
pubmed: 21450688
JAMA Psychiatry. 2013 Nov;70(11):1231-40
pubmed: 24068297
Curr Dir Psychol Sci. 2010 Oct;19(5):319-323
pubmed: 23645975
Eur J Epidemiol. 2018 Sep;33(9):847-858
pubmed: 29536223
IARC Sci Publ. 1980;(32):5-338
pubmed: 7216345
Epidemiology. 2016 Nov;27(6):852-8
pubmed: 27488059
Stat Med. 2003 Aug 30;22(16):2591-602
pubmed: 12898546
Br J Psychiatry. 2014 Nov;205(5):355-61
pubmed: 25257067
Eur J Epidemiol. 2016 Jun;31(6):563-74
pubmed: 27179798
Biostatistics. 2021 Jul 17;22(3):598-612
pubmed: 31804668
Am J Epidemiol. 2008 Sep 15;168(6):656-64
pubmed: 18682488
Biostatistics. 2016 Apr;17(2):264-76
pubmed: 26508769
Popul Stud (Camb). 2020 Nov;74(3):363-378
pubmed: 32052701

Auteurs

Arvid Sjölander (A)

Karolinska Institutet, Nobels väg 12 A, 171 77, Stockholm, Sweden. arvid.sjolander@ki.se.

Sara Öberg (S)

Karolinska Institutet, Nobels väg 12 A, 171 77, Stockholm, Sweden.

Thomas Frisell (T)

Karolinska Institutet, Maria Aspmans Gata 30A, 17164, Solna, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH